Comment from Johanna Ihli
AnonymousSupportIndividual
Summary: Johanna Ihli, a former registered nurse, supports her citizen petition by arguing that current FDA warnings are insufficient to prevent the over-prescription of fluoroquinolones in outpatient settings. She requests that the FDA implement targeted clinician education, strengthened patient counseling, and improved pharmacovigilance to address the disconnect between safety messaging and commercial market growth.
Supplemental comment submitted in support of my Citizen Petition regarding fluoroquinolone-associated disability, delayed multisystem injury, clinician education, informed consent, and pharmacovigilance. Attached PDFs compare current FDA-approved ciprofloxacin labeling, including boxed warning and reserve-use language, with commercial market forecasts projecting fluoroquinolone growth in respiratory infections, UTIs, oral formulations, and outpatient use. The attachments also include a redacted public patient-advocacy example illustrating the need for stronger clinician and patient education.